As of 2025-07-11, the Relative Valuation of Antares Pharma Inc (ATRS) is 7.53 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 34.8%.
The range of the Relative Valuation is 6.55 - 8.49 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 19.6x - 25.5x | 22.6x |
| Fair Price | 6.55 - 8.49 | 7.53 |
| Upside | 17.1% - 51.9% | 34.8% |
| Date | P/E |